Mariana Mihalusova
Biotech in 2026: Changing Tide, but Treacherous Currents
Jan 12
Cleverness, Perseverance, and Efficiency – Three Highlights from FDA’s 2024 Approvals
Nov 11
FDA’s Project Optimus – A Win for Patients, Drug Developers, and Investors Alike
Nov 8
